Quebec · CCAA
List of Exhibits and Exhibits R-1 to R-5
Order (other) · 18 January 2025
A plain-language read of this filing opens with a subscription.
What we verified from this filing7 verified
- closing termsClosing to occur per Schedule E of the Purchase Agreement, with consideration remitted to the Monitor and distributed in priority order
- order date24 January 2025
- presiding officerJustice David R. Collier
- purchaserXediton Pharmaceuticals Inc.
- residualcoResidualCo
- sale outcometext: The Court approved the Purchase and Sale Transactions and Reorganization involving Xediton Pharmaceuticals Inc. as purchaser · scope: whole_business · status: approved
- sealed itemsunredacted Purchase Agreement